Grant of Share Option to PDMR

Craneware plc

13 April 2026

 

Craneware plc

("Craneware" or the "Company")

Grant of Share Option to PDMR

13 April 2026 - The Board of Craneware plc (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 10 April 2026, under the terms of the Craneware plc Employee Stock Purchase Plan (2018) ("the Option Plan"), a share option (the "Option") to acquire 1,004 ordinary shares of 1p each in the Company ("Shares") was granted to Eric Carter, the Company's Chief Legal Officer who is considered to be a person discharging managerial responsibilities ("PDMR").

The Option Plan is a share option scheme operated for all of the employees, based in the United States of America ("US"), of the subsidiaries of the Company. The Option was granted on the same terms as other US employees who chose to participate in the Option Plan. The Option has been granted at an exercise price of £11.594 per Share. The Option will ordinarily become exercisable at the end of a two year savings term.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Eric Carter

2.   Reason for the notification

a) Position / status                                            Chief Legal Officer

b) Initial notification / Amendment                       Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                         Ordinary Shares of 1p each in the capital of Craneware plc

b) Identification code                                         ISIN GB00B2425G68

c) Nature of the transaction                                Grant of option over Ordinary Shares under the Craneware plc Employee Stock Purchase Plan (2018)

d) Price(s) and volume(s)                                   Volume(s) 1,004, Price(s) £11.594

e) Aggregated information:                               

                                    i. Aggregated volume                1,004

                                    ii. Price                                     £11.594

f) Date of the transaction                                  2026-04-10

g) Place of the transaction                                 Outside a trading venue

For further information, please contact:

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications	[phone]
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Virginia Bull, Arnav Kapoor
Berenberg (Joint Broker)	[phone]
Mark Whitmore, Richard Andrews, Patrick Dolaghan

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus^® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

 

END